Aethlon Medical Inc (AEMD)
NASDAQ:AEMD
Want to see AEMD full AI Analyst Report?
Total Valuation
Aethlon Medical has a market cap or net worth of $4.50M. The enterprise value is -$4.86M.
Market Cap$4.50M
Enterprise Value-$4.86M
Share Statistics
Aethlon Medical has 2,370,560 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,370,560
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aethlon Medical’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is >-0.01%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)>-0.01%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee0.00
Profits Per Employee-510.82B
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Aethlon Medical is ―. Aethlon Medical’s PEG ratio is 0.00236.
PE Ratio―
PS Ratio0.00
PB Ratio<0.01
Price to Fair Value<0.01
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio0.00236
Income Statement
In the last 12 months, Aethlon Medical had revenue of 0.00 and earned -7.15M in profits. Earnings per share was -10.61.
Revenue0.00
Gross Profit0.00
Operating Income-7.29M
Pretax Income-7.15M
Net Income-7.15M
EBITDA-7.15M
Earnings Per Share (EPS)-10.61
Cash Flow
In the last 12 months, operating cash flow was -6.92M and capital expenditures 536.00, giving a free cash flow of -6.92M billion.
Operating Cash Flow-6.92M
Free Cash Flow-6.92M
Free Cash Flow per Share-2.92
Dividends & Yields
Aethlon Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.37
52-Week Price Change-90.36%
50-Day Moving Average2.23
200-Day Moving Average3.95
Relative Strength Index (RSI)42.14
Average Volume (3m)688.41K
Important Dates
Aethlon Medical upcoming earnings date is Aug 12, 2026, After Close (Confirmed).
Last Earnings DateJun 10, 2026
Next Earnings DateAug 12, 2026
Ex-Dividend Date―
Financial Position
Aethlon Medical as a current ratio of 3.85, with Debt / Equity ratio of 6.89%
Current Ratio3.85
Quick Ratio3.85
Debt to Market Cap228.14K
Net Debt to EBITDA655.77K
Interest Coverage Ratio-507.49
Taxes
In the past 12 months, Aethlon Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Aethlon Medical EV to EBITDA ratio is 655.77K, with an EV/FCF ratio of 0.67.
EV to Sales0.00
EV to EBITDA655.77K
EV to Free Cash Flow0.67
EV to Operating Cash Flow0.67
Balance Sheet
Aethlon Medical has $6.96M in cash and marketable securities with $417.52K in debt, giving a net cash position of $6.54M billion.
Cash & Marketable Securities$6.96M
Total Debt$417.52K
Net Cash$6.54M
Net Cash Per Share$2.76
Tangible Book Value Per Share$7.25M
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Aethlon Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast81.30%